Cargando…
A new phase of the Cancer Moonshot to end cancer as we know it
Improved screening, novel therapies and a focus on health equity can reduce cancer mortality by 50% in the next 25 years, but these must be underpinned by an investment in basic, translational and clinical research, along with open data.
Autor principal: | Singer, Dinah S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244436/ https://www.ncbi.nlm.nih.gov/pubmed/35760861 http://dx.doi.org/10.1038/s41591-022-01881-5 |
Ejemplares similares
-
COVID-19 and cancer: do we really know what we think we know?
por: Robinson, Andrew G., et al.
Publicado: (2020) -
Cancer and COVID-19: what do we really know?
por: Poortmans, Philip M, et al.
Publicado: (2020) -
Achieving the cancer moonshot in Africa
por: Adewole, Isaac, et al.
Publicado: (2022) -
Moonshots for aging
por: Kumar, Sandeep, et al.
Publicado: (2020) -
Monkeypox: how will we know if the treatments work?
por: Rojek, Amanda, et al.
Publicado: (2022)